Matches in Wikidata for { <http://www.wikidata.org/entity/Q92850013> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q92850013 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92850013 description "scientific article published on 01 April 2019" @default.
- Q92850013 description "wetenschappelijk artikel" @default.
- Q92850013 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q92850013 name "The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial" @default.
- Q92850013 name "The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial" @default.
- Q92850013 type Item @default.
- Q92850013 label "The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial" @default.
- Q92850013 label "The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial" @default.
- Q92850013 prefLabel "The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial" @default.
- Q92850013 prefLabel "The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial" @default.
- Q92850013 P1433 Q92850013-5F3CFF9F-3D78-4A94-A48F-8E88648699AD @default.
- Q92850013 P1476 Q92850013-76A02D40-432E-4472-95FA-0A1B15F5DEC0 @default.
- Q92850013 P2093 Q92850013-0E359EA1-6B71-47A1-B13B-EAF81CE11E42 @default.
- Q92850013 P2093 Q92850013-33D09445-156F-4F74-B14D-A711C59DAF4E @default.
- Q92850013 P2093 Q92850013-624C501B-2395-4E95-AF1E-1E6D5A05F4F7 @default.
- Q92850013 P2093 Q92850013-637C2C85-DB7B-4C4E-A65E-21222DB9E0E0 @default.
- Q92850013 P2093 Q92850013-66B7A292-0904-48D1-8936-248D68297CA2 @default.
- Q92850013 P2093 Q92850013-6ECFB365-4724-4E15-93DD-842F4EB4608A @default.
- Q92850013 P2093 Q92850013-754D9964-A564-4B36-826A-729CA78A9C28 @default.
- Q92850013 P2093 Q92850013-779889D5-F0D8-40C8-9099-6E9B59EC1DE2 @default.
- Q92850013 P2093 Q92850013-8574C8DF-F591-4394-8318-54B96E879C76 @default.
- Q92850013 P2093 Q92850013-8D0700C7-53A6-4576-A3DA-8EF8802CC275 @default.
- Q92850013 P2093 Q92850013-ADD5339A-6ED0-4985-96AC-ADD092E75911 @default.
- Q92850013 P2093 Q92850013-BE8289B6-81A6-402D-A5A9-F23530301BCE @default.
- Q92850013 P2093 Q92850013-CE547073-624D-4E8F-9345-CC11836EF5C0 @default.
- Q92850013 P2093 Q92850013-D9166116-0DB6-441B-9A1E-429904F0DB6C @default.
- Q92850013 P2093 Q92850013-FCC887DA-54F1-43B1-8A4E-CDE16505447B @default.
- Q92850013 P304 Q92850013-29039AE5-6587-4EF1-A604-679550582B9F @default.
- Q92850013 P31 Q92850013-41C19963-C995-468C-979D-CB0331BC90AF @default.
- Q92850013 P356 Q92850013-53F57217-4DF1-40F4-BF67-CB0D74804C93 @default.
- Q92850013 P433 Q92850013-D82DA547-5224-489D-86C9-83924D71F5C7 @default.
- Q92850013 P478 Q92850013-C944744F-F831-46FF-A4C1-F49FD7F34319 @default.
- Q92850013 P577 Q92850013-B7E792EB-DD0D-4C93-91CB-A603F86DDAE9 @default.
- Q92850013 P698 Q92850013-926424FC-0BD1-4600-84EB-66A4237FFF33 @default.
- Q92850013 P921 Q92850013-6946D6ED-8DDA-4368-BED5-75CA6AA07E6B @default.
- Q92850013 P921 Q92850013-69D7CD67-C9E5-45C6-BD8B-8DBABF667FEB @default.
- Q92850013 P356 J.OPHTHA.2019.03.036 @default.
- Q92850013 P698 30946888 @default.
- Q92850013 P1433 Q7098109 @default.
- Q92850013 P1476 "The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial" @default.
- Q92850013 P2093 "Anthony P Adamis" @default.
- Q92850013 P2093 "Carl C Awh" @default.
- Q92850013 P2093 "Carl Regillo" @default.
- Q92850013 P2093 "Dennis M Marcus" @default.
- Q92850013 P2093 "Fan Tang" @default.
- Q92850013 P2093 "Giulio Barteselli" @default.
- Q92850013 P2093 "Jason S Ehrlich" @default.
- Q92850013 P2093 "Joshua Horvath" @default.
- Q92850013 P2093 "Katie F Maass" @default.
- Q92850013 P2093 "Natasha Singh" @default.
- Q92850013 P2093 "Peter A Campochiaro" @default.
- Q92850013 P2093 "Signe Erickson" @default.
- Q92850013 P2093 "Vladimir Bantseev" @default.
- Q92850013 P2093 "William D Hanley" @default.
- Q92850013 P2093 "Yawen Chiang" @default.
- Q92850013 P304 "1141-1154" @default.
- Q92850013 P31 Q13442814 @default.
- Q92850013 P356 "10.1016/J.OPHTHA.2019.03.036" @default.
- Q92850013 P433 "8" @default.
- Q92850013 P478 "126" @default.
- Q92850013 P577 "2019-04-01T00:00:00Z" @default.
- Q92850013 P698 "30946888" @default.
- Q92850013 P921 Q27429789 @default.
- Q92850013 P921 Q42824440 @default.